Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dihydroergotine Mesylate Extended-release Tablets for Drooling in Parkinson's Disease
NCT06319118Phase 4Completed
- Sponsor
- The Second Affiliated Hospital of Soochow University
- Start
- Oct 2023
- Primary completion
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in sialorrhea (2 arms), sponsored by The Second Affiliated Hospital of Soochow University. Primary endpoint: Objective weight of saliva at 12 weeks. Started Oct 2023; status: completed.
02
Conditions
sialorrhea
Beyond the preview
Go deeper on NCT06319118.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06319118.